Strategic partnerships Leverage Ocean Grown Ventures’ established alliance with Panaxia Pharmaceutical Industries and ongoing Israeli-US collaboration to position joint ventures or co-development opportunities in medical cannabis product development, regulatory-compliant manufacturing, and distribution channels.

Pharma-grade positioning Target opportunities highlighting Ocean Grown Ventures’ emphasis on pharmaceutical manufacturing standards for wellness solutions, appealing to institutions, pharmacies, and healthcare providers seeking rigorously tested, high-quality cannabis-based products.

Israel-US bridge Capitalize on the cross-border R&D narrative to propose technology licensing, research collaborations, and clinical study sponsorships that connect Israeli innovations with US market access and regulatory pathways.

Emerging CBD line Promote expansion and distribution of Tikva full-spectrum hemp-derived CBD products to wellness retailers, clinics, and e-commerce channels seeking consistent, premium hemp offerings with traceable sourcing.

Growth-ready flexibility Position as a lean, science-focused company with strategic growth potential suitable for investment, partnerships, or contract manufacturing engagements, given limited headcount and revenue signals but strong industry positioning.